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a b s t r a c t
The vertebrate heart undergoes early complex morphologic events in order to develop key cardiac
structures that regulate its overall function (Fahed et al., 2013). Although many genetic factors that
participate in patterning the heart have been elucidated (Tu and Chi, 2012), the cellular events that drive
cardiac morphogenesis have been less clear. From a chemical genetic screen to identify cellular pathways
that control cardiac morphogenesis in zebraﬁsh, we observed that inhibition of the Rho signaling
pathways resulted in failure to form the atrioventricular canal and loop the linear heart tube. To identify
speciﬁc Rho proteins that may regulate this process, we analyzed cardiac expression proﬁling data and
discovered that RhoU was expressed at the atrioventricular canal during the time when it forms. Loss of
RhoU function recapitulated the atrioventricular canal and cardiac looping defects observed in the ROCK
inhibitor treated zebraﬁsh. Similar to its family member RhoV/Chp (Tay et al., 2010), we discovered that
RhoU regulates the cell junctions between cardiomyocytes through the Arhgef7b/Pak kinase pathway in
order to guide atrioventricular canal development and cardiac looping. Inhibition of this pathway
resulted in similar underlying cardiac defects and conversely, overexpression of a PAK kinase was able to
rescue the loss of RhoU cardiac defect. Finally, we found that Wnt signaling, which has been implicated
in atrioventricular canal development (Verhoeven et al., 2011), may regulate the expression of RhoU at
the atrioventricular canal. Overall, these ﬁndings reveal a cardiac developmental pathway involving
RhoU/Arhgef7b/Pak signaling, which helps coordinate cell junction formation between atrioventricular
cardiomyocytes to promote cell adhesiveness and cell shapes during cardiac morphogenesis. Failure to
properly form these cell adhesions during cardiac development may lead to structural heart defects and
mechanistically account for the cellular events that occur in certain human congenital heart diseases.
& 2014 Elsevier Inc. All rights reserved.
Introduction
In order for the early vertebrate linear heart tube to develop
into a multi-chambered adult heart that optimally pumps blood
throughout the vertebrate vascular system, it must undergo a
series of intricate morphologic transformations (Tu and Chi, 2012).
Although numerous animal models have been generated to
illuminate key gene regulatory networks in heart development
(Olson, 2006), our understanding of the cellular basis for devel-
oping the complex anatomic structures of the heart remains less
clear. Exploiting the advantages of zebraﬁsh, recent studies have
begun to unravel the cellular mechanisms of vertebrate
organogenesis, including cardiac morphogenesis (Auman et al.,
2007; Chi et al., 2008a, 2008b).
One of the ﬁrst crucial morphogenetic events that occur in
early vertebrate cardiac development is atrioventricular (AV) canal
formation and cardiac looping, which appear to be intimately
coupled. Prior to these initial structural changes, the expression of
Bmp2/4 and Tbx2 becomes progressively restricted within the
linear heart tube to establish the boundary that will divide the
atrial and ventricular cardiac chambers (Christoffels et al., 2004;
Kokubo et al., 2007; Ribeiro et al., 2007; Rutenberg et al., 2006;
Verhoeven et al., 2011; Walsh and Stainier, 2001). Furthermore,
Notch signaling through the regulation of Hairy-related transcrip-
tion factors (Hrt) may reﬁne Tbx2's AV myocardial expression by
repressing Bmp2/4 expression in the cardiac chambers (Kokubo
et al., 2007; Rutenberg et al., 2006; Xin et al., 2007). Loss of Tbx2
or Notch/Hrt function, which leads to misexpression of Bmp2/4
and Tbx2 in the cardiac chambers, can result in structural AV canal
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and cardiac looping defects, thus highlighting the importance of the
strict patterning regulation between AV and chamber myocardium.
In zebraﬁsh, the cell morphologic changes that drive cardiac
morphogenesis can be easily observed in vivo because of its optical
transparency and external fertilization. As early as the linear heart
tube stage (24 h postfertilization/hpf), ventricular cardiomyocytes
at the outﬂow tract have already transformed from a squamous to
a cuboidal cell morphology (Auman et al., 2007; Chi et al., 2008b;
Yelon et al., 1999). By 36 hpf when bmp4 and tbx2b are restricted
to the AV myocardium, AV cardiomyocytes exhibit stronger stain-
ing for Alcama (DM-Grasp), a cell-surface adhesion molecule, and
undergo apical membrane constriction, which subsequently leads
to their trapezoidal shape (Beis et al., 2005). Furthermore, these AV
cardiomyocytes as well as their adjacent atrial and ventricular
cardiomyocytes also realign themselves into a circumferential
pattern around the AV canal (Chi et al., 2008b). As a result, these
dynamic AV cardiomyocyte cellular events ultimately lead to
constriction of the heart tube between the cardiac chambers to
form the AV canal and initiate cardiac looping (Beis et al., 2005).
Morpholino knockdown of tbx2b can disrupt these cellular
changes resulting in failure to form the AV canal (Chi et al.,
2008a). Thus, proper cell–cell adhesion is crucial for the regulation
of correct AV cardiomyocyte cell morphology and rearrangement
during AV canal formation. However, the underlying molecular
mechanisms that guide these cellular processes remain to be
elucidated.
Rho GTPases are critical cellular components that drive cell
morphology and migration through regulating cytoskeletal struc-
tures (Etienne-Manneville and Hall, 2002; Heasman and Ridley,
2008) as well as cell adhesions (Fukata and Kaibuchi, 2001;
Gumbiner, 2005; Perez-Moreno et al., 2003). Though RhoA, Rac1,
and Cdc42 Rho GTPase proteins have been extensively investigated
in cell migration, polarization, and morphology (Choi and Han,
2002; Habas et al., 2003; Lai et al., 2005; Sugihara et al., 1998),
other Rho GTPases have been less studied, including the atypical
Rho GTPases (Guemar et al., 2007; Tao et al., 2001). Recent studies
have revealed that the atypical Rho GTPases, RhoV/Chp and RhoU/
Wrch1, which are constitutively in an active GTP-bound state and
have arisen during vertebrate evolution (Wherlock and Mellor,
2002), may regulate cell–cell adhesions through interactions with
the Arhgef7b(β-Pix)/Pak complex and cadherin proteins (Fort
et al., 2011; Tay et al., 2010). To investigate whether these atypical
Rho GTPases may participate in AV cardiomyocyte migration and
morphogenesis by mediating cell adhesiveness, we examined the
expression of rhou in the zebraﬁsh heart and discovered that it
was expressed in the AV canal during its development. Moreover,
morpholino (MO) knockdowns of rhou resulted in AV canal and
cardiac looping defects through disruption of AV cardiomyocyte
cell–cell adhesions, including N-cadherin and Alcama, and the
RhoU/RhoV downstream effector components, Arhgef7b and Pak
proteins, appear to be necessary to maintain N-cadherin and
Alcama at the AV cardiomyocyte cell junctions. Finally, we show
that Wnt signaling may regulate RhoU's developmental cardiac
expression. Overall, these studies uncover a morphogenetic pro-
gram involving a RhoU/Arhgef7b/Pak signaling pathway, which
helps to coordinate cell adhesions between AV cardiomyocytes in
order to control their cell morphology and cell rearrangements
during AV canal formation and cardiac looping.
Materials and methods
Zebraﬁsh strains
Zebraﬁsh embryos and adults were maintained under standard
laboratory conditions as previously described (Hegarty et al., 2013).
The following lines were used: Tg(cmlc2:GFP-ras)s883 (Chi et al.,
2008b), prts404 (Ober et al., 2006), bbhm292 (Liu et al., 2007), and
apcca50a (Hurlstone et al., 2003).
RhoU sequence alignment
RhoU sequence alignment by ClustalW multi-sequence align-
ment were performed as described (Hegarty et al., 2013).
Morpholino knockdown
To knockdown rhoua function, we injected zebraﬁsh embryos at
the one-cell stage with antisense morpholino oligonucleotides (MOs)
targeted against the ATG translational start site with the sequence
5'-CCTGCGGAGGCATCGCTGCAAACAC-3' (MO1) and against the 3'
exon–intron junction of exon 1 with the sequence 5'-AATGCTGGAGT-
GATATTTACCTGCA-3' (MO2). For control morpholino, 5 base pairs (bp)
of the ATG morpholino were altered to create a control 5-bp
mismatched morpholino, which did not cause any discernible pheno-
types. 8 ng of the control and rhoua MOs were used, and the number
of zebraﬁsh injected for each condition is indicated in results section.
To conﬁrm that MO1 blocked the translation of rhoua, 60 base pairs of
the 5' end of rhoua including the MO1 targeted sequences, were
cloned upstream of GFP in a pCS2þ vector. This rhoua-ATG-GFP fusion
construct was transcribed into capped mRNA using an Ambion
mMESSAGE mMACHINE system (#AM1340). 50 pg of the rhoua-
ATG-GFP RNA with or without 8 ng of rhoua MO1 were injected into
zebraﬁsh embryos at the one-cell stage. To conﬁrm that MO2 altered
splicing of rhoua, RT-PCR of rhoua was performed from RNA obtained
from zebraﬁsh embryos injected with 8 ng of MO2. Primer sequences
used for the RT-PCR are the following: rhouaF 5'-CCGGGACGCTGTTTG-
CAGTGT-3'; rhouaR 5'-GGCATCCTGCGGTTCAACTGGTC-3'. Each PCR
product generated was sequenced to determine its identity. To knock-
down tbx2b function, we used a MO targeted against the translational
start site of tbx2b as previously described (Chi et al., 2008a).
RNA overexpression and rescue experiments
For RNA overexpression experiments, full-length zebraﬁsh
rhoua (BC085398) and pak1 (NM_201328) genes were cloned into
a pCS2þ vector and transcribed into RNA using an Ambion
mMESSAGE mMACHINE system (#AM1340). 50, 100, 200, 300, or
400 pg of rhoua and pak1 RNA were injected into embryos at the
one-cell stage. Because larger doses of rhoua and pak1 RNA
resulted in cardiac defects, 50 pg and 200 pg of rhoua respectively,
were used for the rhoua MO rescue experiments. The number of
zebraﬁsh injected for each condition is indicated in results section.
rhoua and bubblehead/arhgef7b genetic interaction studies
Titrated doses of rhoua ATG MO1 (2.5, 5.0, 7.5, 10.0 ng) were
injected into bbh heterozygous (bbhþ/) and wild-type (WT)
homozygous sibling embryos, which were genotyped by a restric-
tion fragment length polymorphism due to the bbh mutation.
Injected embryos were evaluated by brightﬁeld and ﬂuorescence
microscopy to detect whether they had cardiac looping defects.
The number of zebraﬁsh injected for each condition is indicated in
results section.
Expression analysis
Whole mount in situ hybridization was performed as pre-
viously described (Hegarty et al., 2013) using the following probes:
rhoua, vmhc, amhc, cmlc2, tbx2b, bmp4, notch1b, and anf (Auman
et al., 2007; Chi et al., 2008b). Embryos were mounted in 1:1
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benzyl benzoate:benzoic acid and imaged with a Leica M205 FA
stereomicroscope.
Microscopy and cardiomyocyte morphology analysis
Confocal, ﬂuorescence, and brightﬁeld microscopy as well as live
imaging of zebraﬁsh were performed using a Nikon C2 confocal and a
Leica M205 FA stereomicroscope as described (Hegarty et al., 2013).
For confocal imaging, embryos were mounted in low-melt agarose in a
glass bottom culture dish (MatTek) to visualize the heart using a 40
oil immersion objective as previously described (Chi et al., 2010).
Cardiomyocyte surfaces and cross-sections were analyzed from hearts
captured by live confocal imaging using Nikon's NIS-Elements soft-
ware as described previously (Chi et al., 2010). Only cells with clearly
visible outlines were measured in the xy plane of view. Because the
curvatures of some cardiomyocytes were distorted in mutant embryos,
we processed images to focus these cardiomyocytes in the xy focal
plane. Furthermore, we compared pooled circularity and surface area
data obtained from outer curvature (OC), inner curvature (IC), and
atrioventricular (AV) wildtype and morphant ventricular cardiomyo-
cytes. Cardiomyocytes were measured in 5 control embryos (18 OC, 17
IC, 12 AV cells), 7 rhoua MO1 injected embryos (22 OC, 24 IC, 22 AV
cells), 5 DMSO treated embryos (15 OC, 9 IC, 12 AV cells), and 5 ROCK
inhibitor treated embryos (13 OC, 10 IC, 11 AV cells). Circularity
measurements discriminate circular cells (circularity¼1) from ellipti-
cal cells (circularityo1). For movies, the heart was recorded by a high
speed EMCCD Andor camera as previously described (Chi et al., 2010).
Histochemistry
Zebraﬁsh embryos were ﬁxed with 4% paraformaldahyde at
4 1C overnight. They were then washed with PBS and permeabi-
lized with PBS containing 0.5% Triton X-100 – PBST. Blocking was
done with PBST with 4% BSA. Embryos were incubated at 4 1C
overnight with Zn8 (Beis et al., 2005) or N-cadherin (Bagatto et al.,
2006) antibodies at a 1:100 dilution, then incubated with
Alexa594 secondary antibodies, and then washed with PBST prior
to imaging. The number of embryos analyzed for the Zn8/Alcama
and N-cadherin immunostaining was 17 control/23 MO1 embryos
and 14 control/31 MO1 embryos, respectively. For phalloidin
staining in the bubblehead analysis, embryos were incubated at
4 1C overnight with rhodamine-phalloidin at a 1:100 dilution and
then imaged after PBST washes. The number of embryos analyzed
for this study was 8 WT and 11 bubblehead embryos.
ROCK inhibitor injections
Tg(cmlc2:GFP-ras)s883 embryos were injected at the one-cell
stage with 5 nL of a 45 μM solution of Y-27632 (Tocris). Embryos
were mounted in 1% low melt agarose and imaged using a Nikon
C2 confocal microscope.
Results
The atypical Rho GTPase, RhoU, is expressed in AV cardiomyocytes
From a chemical genetic screen in the zebraﬁsh to identify
cellular pathways that may regulate cardiac morphogenesis, we
Table 1
Cell adhesion/junction genes enriched in mouse AV canal when compared to
cardiac chambers.
Gene Gene class Fold-change
Shroom1 Cell elongation (microtuble) 21
Dlgap1 Cell–cell junction 21
Ncam1 Cell adhesion 16
Cldn11 Cell–cell junction 16
Pdlim3 Actin cytoskeleton 14.9
Megf10 Cell adhesion 9.2
Rhou Cell junction (cell morphology) 6.5
Postn Cell adhesion 6.1
Sspn Cell junction 6.1
Dpt Cell adhesion 6.1
Cldn5 Cell–cell junction 6.1
Cdc42ep4 Cytoskeleton (cell shape control) 5.7
Synpo Cytoskeleton (cell shape control) 5.7
Cldn3 Cell–cell junction 5.3
Negr1 Cell adhesion 4.9
Adamts10 Cell migration 4.9
Dchs1 Cell adhesion 4.9
Rhob Cell adhesion 4.3
Mical1 Cytoskeleton 4.3
Dnm1 Cytoskeleton 4.3
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Fig. 1. rhoua is expressed in the heart and brain. (A–H) Whole mount RNA in situ
hybridization reveals rhoua expression in the zebraﬁsh at (A, B) 24 hpf, (C, D)
36 hpf, (E, F) 48 hpf, and (G, H) 72 hpf. (A, C, E, G) Lateral view of the zebraﬁsh head
and torso. White arrow points to heart. (B) Dorsal view of 24 hpf zebraﬁsh head. (D,
F, H) Ventral view of heart. Anterior is to the top. Dashed lines outline the heart.
Arrowhead points to AV canal. At – atrium, V – ventricle.
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found that inhibition of the Rho associated protein kinase (ROCK)
pathways resulted in AV canal defects and linear hearts at 48 hpf
when AV canal formation and cardiac looping has initiated in
the zebraﬁsh (Fig. S1). Utilizing the Tg(cmlc2:eGFP-ras)s883 line (Chi
et al., 2008a, 2008b) which outlines individual cardiomyocytes
with membrane bound GFP, we further analyzed the cellular
shape characteristics of ROCK inhibitor-treated hearts by confocal
microscopy at 60 hpf (Fig. S1A–D). Examination of the surface of
cardiomyocytes from control zebraﬁsh embryos revealed that AV
cardiomyocytes were elongated (Fig. S1A), as previously reported
(Auman et al., 2007; Chi et al., 2008b), whereas the morphology
of AV cardiomyocytes from ROCK-inhibitor treated embryos
appeared signiﬁcantly altered and was correlated with loss of AV
canal constriction and a linearized heart (Fig. S1B). In particular,
ROCK inhibitor treated AV cardiomyocytes were signiﬁcantly
larger than control treated AV cardiomyocytes (Fig. S1E and F).
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Fig. 2. Loss of rhoua results in cardiac edema due to morphologic atrioventricular (AV) canal defects. (A) The following regions of rhoua were targeted to create the rhoua
ATG (MO1) and splice (MO2) morpholinos (MO). (B–D) Brightﬁeld microscopy imaging shows that rhoua ATG and splice MO injected embryos (C, D) exhibited cardiac edema
(red arrows) by 60 hpf, but control MO injected embryos (B) did not. (E–G) Confocal projections of 60 hpf Tg(cmlc2:ras-eGFP) (E) control MO, (F) rhoua ATG MO1, and (G)
rhoua splice MO2 injected zebraﬁsh revealed that rhoua MO injected zebraﬁsh hearts failed to undergo proper cardiac looping and displayed AV canal defects. White arrow
points to AV canal. Outer curvature (OC), inner curvature (IC), and atrioventricular canal (AV) are outlined in yellow, orange, and red dashed lines, respectively. At– atrium, V
– ventricle. Inset shows representative AV cardiomyocytes, which appear more rounded and larger in MO injected embryos compared to control embryos. (H, I) Bar graphs
represent cardiomyocyte (H) surface area and (I) morphology/circularity measurements of control and ATG MO1 Tg(cmlc2:ras-eGFP) hearts at 60 hpf. Meanþs.e.m. Student's
t-test, *po0.05 (n¼5 control and 7 rhouamorpholino injected zebraﬁsh hearts). (J) 88.7% and 73.3% of zebraﬁsh embryos injected with a rhoua ATG (MO1) and splice (MO2)
MOs exhibited cardiac edema and AV canal defects, but wild-type embryos injected with control MO did not (0%). Injection of 150 pg of wild-type zebraﬁsh rhouawas able to
rescue the cardiac phenotype in the rhoua ATG and splice MO injected zebraﬁsh and reduce the mutant phenotype to 36.9% and 21.7% for ATG MO1 (MO1þrhoua) and splice
MO2 (MO2þrhoua), respectively. n indicates the number of embryos with cardiac phenotype/total number of embryos injected for each condition.
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Because of the AV cardiomyocyte changes observed after
inhibition of ROCK signaling pathways, we analyzed existing AV
canal microarrays (Horsthuis et al., 2009; Wirrig et al., 2007) to
identify speciﬁc Rho GTPases that may be enriched in AV cardio-
myocytes and could regulate this AV canal morphogenesis and
cardiac looping. As a result, we discovered that RhoU expression in
the mouse AV canal was 6.5 times greater than that observed in
the mouse cardiac chambers (Table 1). Protein sequence compar-
ison using the ClustalW program revealed that RHOU is highly
conserved across vertebrate species (Fig. S2A) and genetic analysis
showed that the rhou zebraﬁsh ortholog may be gene duplicated,
resulting in a rhoua and a rhoub gene on chromosome 13 and 15,
respectively (Fig. S2B). Additionally, zebraﬁsh Rhoua and Rhoub
proteins share 73% and 65% homology with human RHOU, and
alignment and synteny studies revealed that rhoua may be more
closely related to mammalian RhoU (Fig. S2A–C). Though rhoub
appears to be primarily expressed in the nervous system by whole
mount in situ analysis (data not shown), we observed that rhoua
was not only expressed in the nervous system but also in the
developing heart (Fig. 1) further supporting the conserved cardiac
role of RhoU. Speciﬁcally, rhoua expression was present through-
out the heart tube by 36 hpf (Fig. 1C and D) but progressively
became more restricted to the AV canal region from 48–72 hpf
when AV canal formation and cardiac looping occurs (Fig. 1E–H).
RhoU is required for AV cardiomyocyte cell shape changes
Because of its AV canal expression and conserved sequence to
mammalian RhoU, we designed morpholinos (MOs) against zebra-
ﬁsh rhoua to further investigate the role of RhoU during cardiac
morphogenesis (Fig. 2A). The rhoua ATG morpholino (MO1) targets
the translational initiation start site and its surrounding
sequences, whereas the rhoua splice morpholino (MO2) targets
the splice junction boundary sequences between exon 1 and
intron 1 (Fig. 2A). 8 ng of either MO1 or MO2 injected into
zebraﬁsh embryos resulted in cardiac edema due to cardiac loop-
ing and AV canal defects by 48–60 hpf (Fig. 2C, D, F, G, and J);
however, these embryos appeared to otherwise develop and swim
normally, suggesting that rhoubmay act redundantly with rhoua to
regulate neural development and function. To examine more
closely the effects of knocking down RhoU function on AV canal
development, we analyzed cardiomyocyte cell morphology using
the Tg(cmlc2:eGFP-ras)s883 line. The cardiac chambers can be
divided into three major regions – the outer curvature/OC (the
greater, convex curvature of the cardiac chamber), the inner
curvature/IC (the lesser, concave curvature of the cardiac cham-
ber), and the atrioventricular canal/AV (the region between the
atrial and ventricular chambers) (Fig. 2E–G – yellow, orange, and
red outlined regions of the heart, respectively), and previous
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Fig. 3. rhoua knockdown does not affect cardiac cell fate speciﬁcation and patterning. In situ analysis of AV and chamber speciﬁc cardiac genes revealed that cardiac cell fate
speciﬁcation and patterning were not perturbed in rhoua ATG MO injected zebraﬁsh embryos. (A, B) vmhc and (C, D) amhc expression were restricted to the ventricular and
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expressed more broadly in the AV canal of (F, H, J) rhouaMO1 injected embryos when compared to (E, G, I) control MO injected embryos. (K, L) Conversely, anfwas expressed
in the chambers but not at the AV canal in (K) control and (L) rhoua MO injected embryos. Ventral view of heart. Anterior is to the top. Dashed lines outline the heart.
Arrowhead points to AV canal. At – atrium, V – ventricle.
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studies have shown that the ventricular cardiomyocytes for each
region exhibit distinct cellular morphology (Auman et al., 2007;
Chi et al., 2008b). For instance, the surface of wildtype AV and OC
ventricular cardiomyocytes are elongated whereas IC ventricular
cardiomyocytes are more round (Fig. 2E and I), as previously
reported. However, similar to the AV cardiomyocytes from ROCK
inhibitor treated embryos, the morphology of AV cardiomyocytes
from rhoua MO1 and MO2 injected embryos appeared more round
with a larger surface area compared to control AV cardiomyocytes
and was correlated with loss of AV canal constriction (Fig. 2F–I). To
validate the speciﬁcities of the rhoua MO knockdowns, MO1 was
able to inhibit the expression of a Rhoua-GFP fusion protein (Fig.
S3A–D), and MO2 disrupted the splicing of rhoua by RT-PCR (Fig.
S3E and F). Furthermore, co-injection of 150 pg of wild-type rhoua
RNA with either rhoua MO1 or MO2 signiﬁcantly reduced the
ability of either MO to reproduce the cardiac phenotype (Fig. 2J), in
effect rescuing the rhoua MO knockdowns. Although injection of
150 pg of wild-type rhoua into zebraﬁsh embryos had no effect on
zebraﬁsh development (Fig. S4B and F, n¼33), injection of 300 pg
of wild-type rhoua interestingly produced enlarged hearts and
cardiac edema (Fig. S4C red arrow, G, n¼55/77).
RhoU does not affect AV cardiomyocyte speciﬁcation and patterning
To investigate whether the rhoua MO knockdown AV canal
defect is due to cardiac patterning defects, we analyzed the
expression of several cardiac AV and chamber speciﬁc markers in
the rhoua knockdown zebraﬁsh embryos. Because the AV boundary
genes are expressed throughout the anteroposterior extent of the
WT heart at early stages (up to 30–36 hpf) (Hurlstone et al., 2003;
Walsh and Stainier, 2001), we performed whole mount in situ
hybridization analysis at 48 hpf when the expression of these genes
becomes restricted to the AV canal and outﬂow tract. As a result, we
discovered that the cardiac chamber speciﬁc markers amhc and
vmhc appeared unaffected in rhoua knockdown zebraﬁsh embryos
(Fig. 3A–D). However, the expression of AV myocardial markers,
bmp4 and tbx2b, appeared to be expanded throughout the AV canal,
when compared to the control MO injected embryos (compare
Fig. 3E, G to F, H). This expression pattern may be due to the failure
of the AV canal cardiomyocytes to elongate, to reduce their surface
area, and to realign circumferentially around the AV canal (Fig. 2F, G,
H, and I), thus leading to the increased area of the AV boundary
region. Interestingly, the expansion of the bmp4 and tbx2b AV
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myocardial expression is accompanied by the broader AV endocar-
dial expression of notch1b as well (compare Fig. 3I–J). Finally, anf, a
marker for OC cardiomyocytes, appears to be heterogeneously
expressed throughout the heart, including in the IC cardiomyocytes
(compare Fig. 3K–L). This anf misexpression may be due to the
disrupted cardiac ﬂow from the inability to form an AV canal
(compare Movie S1–S2) as previously suggested (Auman et al.,
2007; Vermot et al., 2009). Overall, we conclude that Rhoua is not
directly involved in cardiac cell fate speciﬁcation and patterning,
but disruption of Rhoua function may instead likely affect the
morphogenesis and ﬁnal organization of the AV cardiomyocytes.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.02.014.
RhoU regulates the localization of AV cardiomyocyte cell adhesion
molecules
Because one of the major roles of RhoU is to regulate cell
junctions (Fort et al., 2011; Tay et al., 2010), we further investi-
gated whether MO knockdown of rhoua may alter AV cardiomyo-
cyte morphology and realignment through disrupting cell
adhesions between cardiomyocytes. Previous studies have shown
that both N-cadherin and Alcama proteins are present between
cardiomyocytes in the developing heart (Bagatto et al., 2006; Beis
et al., 2005). Furthermore, loss of N-cadherin function in the glass
onion mutant results in malformed hearts where they fail to form
an AV canal and undergo cardiac looping (Bagatto et al., 2006).
Thus, we further examined and compared the expression and
localization of both these proteins in control and rhoua MO
knockdown zebraﬁsh embryos (Fig. 4). As a result, we observed
N-cadherin and Alcama primarily at the cell junctions of AV
cardiomyocytes in control hearts (Fig. 4A and C). However, in the
rhoua knockdown embryos, we observed that Alcama and
N-cadherin were mislocalized in many of the AV cardiomyocytes
(Fig. 4B and D, yellow arrows). In particular, Alcama and
N-cadherin were not only downregulated at the AV cardiomyocyte
cell junctions but also nowmore localized in the cytoplasm as well
as on the apical and basal cell membrane (Fig. 4B‴, B″″, D‴, D″″,
yellow arrows).
Loss of Arhgef7b function phenocopies RhoU loss
Previous studies have shown that Arhgef7b forms a complex
with the ArfGAP GIT1 to recruit the Pak kinase to adhesion
complexes and centrosomes (Liu et al., 2007; Manser et al., 1998;
Obermeier et al., 1998; Zhao et al., 2005), and the atypical Rho
GTPase Rhov/Chp may regulate cell–cell junction through this
Arhgef7b/Pak signaling pathway (Tay et al., 2010). Furthermore,
biochemical studies have revealed that both zebraﬁsh Rhov and
Rhoua form a complex with phospho-Pak1 and phospho-Pak2
(Tay et al., 2010). Finally, both Arhgef7b and Pak2a are essential
for maintaining the integrity of the blood brain barrier (Buchner
et al., 2007; Liu et al., 2007). Thus, we hypothesized that Rhoua may
regulate AV cardiomyocyte cell–cell adhesion through the Arh-
gef7b/Pak complex. To test this possibility, we examined the
arhgef7b mutant, bubblehead/bbhm292 (Fig. 5) and discovered that
these mutants exhibited similar cardiac defects as the rhoua MO
injected zebraﬁsh embryos, including cardiac edema due to AV
canal defects (Fig. 5E and F). Additionally, bbh mutants also
displayed mislocalization of Alcama and N-cadherin in AV cardio-
myocytes (Fig. 5G and H arrows), resulting in the inability of AV
cardiomyocytes to constrict their apical membrane to form the AV
canal. To further support that Rhoua may interact with Arhgef7b to
mediate AV canal formation, we examined the synergistic effects of
combined partial loss of function of Arhgef7b and Rhoua by
injecting titrated doses of rhoua MO1 into the arhgef7bþ /m292
heterozygous embryos (Fig. 5I). As a result, increasing titrated doses
of rhoua MO1 from 2.5 ng to 10 ng into arhgef7bþ /m292 embryos
resulted in a greater dose-dependent increase in cardiac edema and
AV canal defects compared to wild-type (WT) embryos injected
with similar amounts of rhoua MO1 (Fig. 5I, WTþ2.5, 5, 7.5, 10 ng
MO1, n¼0/115, 28/131, 87/165, 134/151 and arhgef7bþ /m292þ2.5, 5,
7.5, 10 ng MO1, n¼4/26, 9/24, 24/30, 33/33). Thus, these results
show that the RhoU downstream effectors that regulate AV cardi-
omyocyte cell adhesion and cell shape may include the Arhgef7b/
Pak signaling pathway.
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Fig. 5. Arhgef7b is required to localize N-cadherin and Alcama to the cell junctions.
(A, E) Brightﬁeld microscopy showed that (E) the arhgef7b mutant, bubblehead
(bbh), exhibited cardiac edema (red arrow) and cranial hemorrhaging (asterisk) by
60 hpf. (B, F) Confocal projections of 60 hpf control wild-type sibling and bbh
mutant phalloidin stained (F-actin) hearts revealed that bbhmutant hearts failed to
undergo proper cardiac looping and displayed AV canal defects. White arrowhead
points to AV canal. (C, D, G, H) Immunohistochemical staining of control and bbh
mutant hearts at 60 hpf using (C, G) Alcama and (D, H) N-Cadherin antibodies,
revealed mislocalization of Alcama and N-cadherin in bbh mutant AV cardiomyo-
cytes (G, H – white arrow). At – atrium, V – ventricle. (I) bbh/arhgef7b genetically
interacts with rhoua. Cardiac edema and AV canal defects were observed more
frequently in bbh þ/ embryos than in wild-type embryos upon increasing
titrated doses of rhoua MO1. (WTþ2.5, 5, 7.5, 10 ng MO1 – 0%, 21.4%, 52.7%,
88.7% cardiac phenotype and arhgef7bþ /m292þ2.5, 5, 7.5, 10 ng MO1 – 15.4%, 37.5%,
78.9%, 100% cardiac phenotype).
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pak1 rescues rhoua MO1 and bbh/arhgef7b mutant cardiac
phenotypes
Previous studies have shown that constitutively active Pak mutants
can rescue the bbh vascular mutant phenotype (Liu et al., 2007) as well
as cause similar cranial neural crest migration defects that are
observed upon RhoU overexpression in Xenopus (Fort et al., 2011).
Thus, we tested whether pak1 may be able to rescue the AV canal
defects observed in rhouaMO injected embryos (Fig. 6). As a result, we
observed that injection of 200 pg of pak1 RNA nearly rescued 50% of
the rhoua MO knockdown cardiac phenotype (Fig. 6B, D, E, and F,
n¼55/114 MO1þpak1 compared to n¼134/151 MO1 only). Although
injection of 200 pg of pak1 had no signiﬁcant effect on ventricular
morphology in wild-type embryos (Fig. 6B, n¼0/87), we observed that
injection of 400 pg of pak1 resulted in dysmorphic hearts (Fig. 6C,
n¼71/83) as similarly observed in high-dose expression (300 pg) of
rhoua (Fig. S4). Interestingly, we also observed that the atrium of the
200 pg of pak1 injected embryos appeared to be larger than in control
hearts (Fig. 6B, n¼57/72).
Wnt signaling may regulate the expression of rhoua at the AV canal
Previous studies have shown that Wnt signaling may act upstream
of RhoU to control its expression (Tao et al., 2001). Additionally, recent
studies have shown that Wnt signaling may regulate AV canal and
leaﬂet formation in the zebraﬁsh (Hurlstone et al., 2003; Verhoeven
et al., 2011), and wnt2bb, which is expressed in the AV canal of
zebraﬁsh has been suggested to regulate AV canal formation (Ober
et al., 2006). To investigate whether Wnt signaling could regulate
rhoua expression in the AV canal, we examined the expression of
rhoua in loss and gain of Wnt signaling zebraﬁsh mutants. In the
apcca50a (Hurlstone et al., 2003), we observed an upregulation of rhoua
expression throughout the heart at 48 hpf (Fig. 7B). In contrast, rhoua
expression was reduced in the AV canal of the wnt2bb mutant,
prometheus/prts404; however, low levels of rhoua expression were still
present in the ventricle (Fig. 7C). Finally, because loss of Tbx2 function
results in AV canal defects (Chi et al., 2008a; Ribeiro et al., 2007), we
further analyzed rhoua expression in tbx2b MO injected embryos and
discovered that it was absent in the AV canal region (Fig. 7D),
suggesting that Tbx2 may mediate AV canal morphogenesis through
regulating rhoua AV canal expression.
Discussion
Tissue morphogenesis plays a critical role towards the develop-
ment of key anatomical structures that allow for organs to function
properly. In particular, the vertebrate heart has evolved from a
primitive heart tube that is present in invertebrates (Bodmer et al.,
1990; Davidson and Levine, 2003), to a multi-chambered yet relatively
asymmetric organ that is dependent on its form to efﬁciently drive
blood through the vertebrate circulatory system. Structural defects of
the heart are amongst the most common and devastating birth defects
in humans, occurring in at least 1–2% of live births (Hoffman and
Kaplan, 2002) and are frequently caused by errors in gene regulatory
networks controlling cardiac development (Gruber and Epstein, 2004;
Fahed et al., 2013). However, our understanding of how these
developmental programs modulate cell behavior during heart mor-
phogenesis remains largely unexplored. Furthermore, as we embark
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on cardiac stem cell-based therapy for the multitude of cardiac
diseases including congenital and adult, such knowledge may also
aid us in the future to ensure proper integration andmorphogenesis of
transplanted cardiac stem cells. Thus, taking advantage of the zebra-
ﬁsh's relatively small heart where the AV canal consists of 40
endocardial cells and fewer than 100 myocardial cells (Beis et al.,
2005), we have begun to elucidate the crucial cellular events that
control cardiac morphogenesis, starting with one of the earliest events
to occur after heart tube formation, AV canal formation and cardiac
looping.
Recent studies have shown that the atypical Rho GTPases,
RhoV/Chp and RhoU/Wrch1, may regulate cell migration during
zebraﬁsh gastulation (Tay et al., 2010) and Xenopus cranial neural
crest migration (Fort et al., 2011), respectively. In both cases, the
Arhgef7b/Pak signaling pathway appears to act downstream of
these atypical Rho GTPases to mediate cell adhesions. Here, we
have discovered that RhoU may direct the cell shape changes
required for the heart tube to constrict at the AV boundary to form
the AV canal. Similar to the down-regulation of E-cadherin at the
cell junctions in rhov morpholino-injected zebraﬁsh embryos
during epiboly, we observed that both N-cadherin and the cell
adhesion molecule, Alcama, were mislocalized in AV cardiomyo-
cytes of rhoua morpholino injected zebraﬁsh embryos. Further-
more, we found that Pak1 kinase was able to partially rescue the
rhoua knockdown zebraﬁsh cardiac phenotypes, supporting pre-
vious biochemical studies that show that the Arhgef7b/Pak com-
plex may interact with zebraﬁsh Rhoua (Liu et al., 2007; Tay et al.,
2010). By contrast, we observed that the arhgef7b mutant, bbh,
phenocopied the AV canal defects observed in the rhoua morpho-
lino injected zebraﬁsh embryos albeit less severe, suggesting that
additional RhoU effectors may exist to mediate AV cardiomyocyte
cell morphogenesis. One possibility is that Rac-dependent path-
ways, which have been previously implicated as downstream
effectors of atypical Rho GTPases, could also regulate AV cardio-
myocyte cell adhesion and its subsequent cell morphogenesis
(Wherlock and Mellor, 2002).
Interestingly, high-dose rhoua and pak1 overexpression through-
out the heart resulted in larger dysmorphic hearts, indicating that
strict regulation of the activity of RhoU and its downstream effectors
is required to ensure coordinated tissue morphogenesis. As a result,
RhoU appears to be restricted to only the AV canal during early
cardiac development, and consistent with previous studies (Tao et al.,
2001), we observed that Wnt signaling may regulate RhoU expres-
sion. Speciﬁcally, rhoua expression was expressed throughout the
heart in apc mutants, but absent in the wnt2bb/prt mutant, suggest-
ing that the AV-speciﬁc wnt2bb may regulate rhoua expression.
Furthermore, we discovered that morpholino knockdown of tbx2b,
a T-box transcription factor restricted to the AV canal, also resulted in
loss of rhoua expression at the AV canal, possibly helping to explain
the previously described AV canal defects in Tbx2 mutants (Chi et al.,
2008a; Harrelson et al., 2004; Ribeiro et al., 2007). Interestingly
recent studies have shown that Wnt signaling may regulate AV canal
formation upstream of Tbx2 (Verhoeven et al., 2011), further sup-
porting the possibility that Tbx2 may regulate rhoua expression in
the heart. Alternatively, to ensure that RhoU acts only on the AV
cardiomyocytes, it is possible that both Wnt signaling and Tbx2 may
independently restrict RhoU expression to the AV canal. Thus,
additional rhoua promoter/enhancer studies will be required to
resolve whether Tbx2 and/or Wnt signaling may transcriptionally
modulate RhoU expression.
Recent studies have shown how cell adhesion molecules may
regulate cell shape and subsequently tissue morphogenesis. Simi-
lar to our rhoua morpholino studies, loss of N-cadherin function in
the heart leads to early primitive heart tube defects such as the
inability of the heart tube to undergo cardiac looping (Bagatto
et al., 2006; Radice et al., 1997). However, further Alcama func-
tional studies will be required to determine whether Alcama is
similarly required to regulate cardiac looping. Furthermore,
N-cadherin appears to be differentially expressed across the gut
tube in order to regulate gut looping. In particular, N-cadherin
expression is increased at the inner curvature but decreased at the
outer curvature of the looping gut tube. Interestingly, Isl1, Pitx2,
and Tbx18 are required to differentially regulate N-cadherin
expression during gut looping (Davis et al., 2008). Because Wnt
and Tbx2 may regulate RhoU expression in the heart and RhoU
may modulate N-cadherin localization to the cell junctions of
cardiomyocytes, it will be particularly interesting to investigate
whether atypical Rho GTPases, such as RhoU may also regulate
N-cadherin expression in the gut tube as well. Conversely, addi-
tional studies are warranted to determine whether cell adhesion
molecules are also differentially expressed across the heart tube to
control cardiac looping and if atypical Rho GTPases, such as RhoU,
may regulate their speciﬁc expression pattern and cellular
localization.
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